SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today ...
Some results have been hidden because they may be inaccessible to you